Foresite Capital Management V, LLC - 01 Dec 2022 Form 4 Insider Report for PARDES BIOSCIENCES, INC.

Role: 10%+ Owner
Signature: /s/ Dennis Ryan, on behalf of Foresite Capital Management V, LLC
Issuer symbol: N/A
Transactions as of: 01 Dec 2022
Net transactions value: +$541,807
Form type: 4
Filing time: 05 Dec 2022, 15:24:15 UTC
Previous filing: 13 Jun 2022
Next filing: 03 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRDS	Common Stock	Purchase	$541,807	+637,420	+5.2%	$0.8500	12,809,810	01 Dec 2022	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 1, 2022, Foresite Capital Fund V, L.P. ("Capital Fund V L.P.") purchased 637,420 shares of the Issuer's Common Stock at an aggregate price of approximately $0.85 per share, or $541,807 in the aggregate, in open market purchases. Foresite Capital Management V, LLC ("FCMVLLC") is the general partner of Capital Fund V L.P. Each of FCMVLLC and Dr. Tananbaum, in his capacity as managing member of FCMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.

Content

On December 1, 2022, Foresite Capital Fund V, L.P. ("Capital Fund V L.P.") purchased 637,420 shares of the Issuer's Common Stock at an aggregate price of approximately $0.85 per share, or $541,807 in the aggregate, in open market purchases. Foresite Capital Management V, LLC ("FCMVLLC") is the general partner of Capital Fund V L.P. Each of FCMVLLC and Dr. Tananbaum, in his capacity as managing member of FCMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.